These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8606591)

  • 21. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of vancomycin-resistant enterococci from animal feed in USA.
    Schwalbe RS; McIntosh AC; Qaiyumi S; Johnson JA; Morris JG
    Lancet; 1999 Feb; 353(9154):722. PubMed ID: 10073518
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of vancomycin-resistant enterococci isolates from human, poultry and pigs in Korea.
    Seo KS; Lim JY; Yoo HS; Bae WK; Park YH
    Vet Microbiol; 2005 Apr; 106(3-4):225-33. PubMed ID: 15778028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin resistance in gram-positive cocci.
    Courvalin P
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to glycopeptides in enterococci.
    Leclercq R; Courvalin P
    Clin Infect Dis; 1997 Apr; 24(4):545-54; quiz 555-6. PubMed ID: 9145724
    [No Abstract]   [Full Text] [Related]  

  • 26. Vancomycin resistance and avoparcin.
    Mudd A
    Lancet; 1996 May; 347(9012):1412. PubMed ID: 8637369
    [No Abstract]   [Full Text] [Related]  

  • 27. Vancomycin-resistant enterococci; the ultimate nosocomial pathogen?
    Mahon CR; Bowman S
    Clin Lab Sci; 1998; 11(3):133-6. PubMed ID: 10181154
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection and characterization of vancomycin-resistant enterococci in farm animals and raw meat products in Italy.
    Del Grosso M; Caprioli A; Chinzari P; Fontana MC; Pezzotti G; Manfrin A; Giannatale ED; Goffredo E; Pantosti A
    Microb Drug Resist; 2000; 6(4):313-8. PubMed ID: 11272260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it time to ban all antibiotics as animal growth-promoting agents?
    Mudd AJ
    Lancet; 1996 Nov; 348(9039):1454; author reply 1455-6. PubMed ID: 8937306
    [No Abstract]   [Full Text] [Related]  

  • 30. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee.
    Emerg Infect Dis; 1995; 1(2):66. PubMed ID: 8979849
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin.
    Sørum M; Johnsen PJ; Aasnes B; Rosvoll T; Kruse H; Sundsfjord A; Simonsen GS
    Appl Environ Microbiol; 2006 Jan; 72(1):516-21. PubMed ID: 16391086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of vancomycin resistance in multiple clones of Enterococcus faecium isolated from Danish broilers 15 years after the ban of avoparcin.
    Bortolaia V; Mander M; Jensen LB; Olsen JE; Guardabassi L
    Antimicrob Agents Chemother; 2015 May; 59(5):2926-9. PubMed ID: 25712360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    Sweeney D; Stoneburner A; Shinabarger DL; Arhin FF; Belley A; Moeck G; Pillar CM
    J Antimicrob Chemother; 2017 Feb; 72(2):622-624. PubMed ID: 27856721
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of banning avoparcin on VRE carriage in The Netherlands.
    van den Bogaard AE; Bruinsma N; Stobberingh EE
    J Antimicrob Chemother; 2000 Jul; 46(1):146-8. PubMed ID: 10882707
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vancomycin-resistant enterococci].
    Kalenić S; Plecko V; Senji P; Tripković V; Jelić I; Vegar V; Dadić D; Boduen Z
    Lijec Vjesn; 1997 Nov; 119(10):298. PubMed ID: 9531765
    [No Abstract]   [Full Text] [Related]  

  • 36. In-vitro susceptibility to LY333328 of vancomycin-resistant enterococci isolated from humans and animals.
    van Tiel FH; van den Bogaard TE
    J Antimicrob Chemother; 1997 Nov; 40(5):733-4. PubMed ID: 9421326
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366).
    Shlaes DM; Al-Obeid S; Shlaes JH; Williamson R
    J Infect Dis; 1989 Jun; 159(6):1132-5. PubMed ID: 2524533
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of vancomycin resistant enterococci on poultry farms established after the ban of avoparcin.
    Sørum M; Holstad G; Lillehaug A; Kruse H
    Avian Dis; 2004 Dec; 48(4):823-8. PubMed ID: 15666863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame?
    van den Bogaard AE; Mertens P; London NH; Stobberingh EE
    J Antimicrob Chemother; 1997 Sep; 40(3):454-6. PubMed ID: 9338505
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.